Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans

Hepatology

Volumn 60, Issue 1, 2014, Pages 257-266

  Starlinger, Patrick ^a   Assinger, Alice ^a   Haegele, Stefanie ^a   Wanek, David ^a   Zikeli, Silvia ^a   Schauer, Dominic ^a   Birner, Peter ^a   Fleischmann, Edith ^a   Gruenberger, Birgit ^b   Brostjan, Christine ^a   Gruenberger, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Institute of Physiology Medical University of Vienna ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER REGENERATION; LIVER RESECTION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; MORBIDITY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEROTONIN BLOOD LEVEL; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MIDDLE AGED; MORBIDITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; SEROTONIN; YOUNG ADULT;

EID: 84903215763     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26950     Document Type: Article

References (36)

1. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006;94:982-999.
2. Van Cutsem E, Nordlinger B, Adam R, Kohne CH, Pozzo C, Poston G, et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 2006;42:2212-2221.
3. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009;27:3677-3683.
4. Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006;13:1271-1280.
5. Wei AC, Tung-Ping Poon R, Fan ST, Wong J. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 2003;90:33-41.
6. Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, et al. Hepatic insufficiency and mortality in 1, 059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007;204:854-862; discussion, 862-854.
7. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007;213:286-300.
8. Clavien PA. Liver regeneration: a spotlight on the novel role of platelets and serotonin. Swiss Med Wkly 2008;138:361-370.
9. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, et al. Platelet-derived serotonin mediates liver regeneration. Science 2006;312:104-107.
10. Kaneko K, Shirai Y, Wakai T, Yokoyama N, Akazawa K, Hatakeyama K. Low preoperative platelet counts predict a high mortality after partial hepatectomy in patients with hepatocellular carcinoma. World J Gastroenterol 2005;11:5888-5892.
11. Soubrane O, Brouquet A, Zalinski S, Terris B, Brezault C, Mallet V, et al. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome. Ann Surg 2010;251:454-460.
12. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003;299:76.
13. Balasubramanian S, Paulose CS. Induction of DNA synthesis in primary cultures of rat hepatocytes by serotonin: possible involvement of serotonin S2 receptor. Hepatology 1998;27:62-66.
14. Sulaiman P, Joseph B, Kaimal SB, Paulose CS. Decreased hepatic 5-HT1A receptors during liver regeneration and neoplasia in rats. Neurochem Res 2008;33:444-449.
15. Nagao Y, Akahoshi T, Kamori M, Uehara H, Hashimoto N, Kinjo N, et al. Liver regeneration is promoted by increasing serotonin content in rat liver with secondary biliary cirrhosis. Hepatol Res 2011;41:784-794.
16. Papadimas GK, Tzirogiannis KN, Panoutsopoulos GI, Demonakou MD, Skaltsas SD, Hereti RI, et al. Effect of serotonin receptor 2 blockage on liver regeneration after partial hepatectomy in the rat liver. Liver Int 2006;26:352-361.
17. Liu Y, Zhang ZY. Serotonin receptor agonist quipazine promotes proliferation and apoptosis of human hepatocyte strain of L-02 strain. Hepatobiliary Pancreat Dis Int 2009;8:278-281.
18. Tian Y, Graf R, El-Badry AM, Lesurtel M, Furrer K, Moritz W, et al. Activation of serotonin receptor-2B rescues small-for-size liver graft failure in mice. Hepatology 2011;53:253-262.
19. Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 2005;12:351-355.
20. Krieger PM, Tamandl D, Herberger B, Faybik P, Fleischmann E, Maresch J, et al. Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing. Ann Surg Oncol 2011;18:1644-1650.
21. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005;242:824-828, discussion, 828-829.
22. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
23. Starlinger P, Alidzanovic L, Schauer D, Brugger P, Sommerfeldt S, Kuehrer I, et al. Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts. Dis Markers 2011;31:55-65.
24. Starlinger P, Moll HP, Assinger A, Nemeth C, Hoetzenecker K, Gruenberger B, et al. Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes. J Thromb Haemost 2010;8:1809-1819.
25. Brand T, Anderson GM. The measurement of platelet-poor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clin Chem 2011;57:1376-1386.
26. Starlinger P, Brugger P, Schauer D, Sommerfeldt S, Tamandl D, Kuehrer I, et al. Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment. Neoplasia 2011;13:419-427.
27. Starlinger P, Schauer D, Alidzanovic L, Zikeli S, Gebhardt K, Luf F, et al. Clinical evidence for thrombospondin-1 as a relevant suppressor of liver regeneration. J Hepatol 2013;58:1053-1054.
28. Ge S, Woo E, Haynes CL. Quantal regulation and exocytosis of platelet dense-body granules. Biophys J 2011;101:2351-2359.
29. Maurer-Spurej E, Pittendreigh C, Solomons K. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost 2004;91:119-128.
30. Alkozai EM, Nijsten MW, de Jong KP, de Boer MT, Peeters PM, Slooff MJ, et al. Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg 2010;251:300-306.
31. Handin RI. Inherited platelet disorders. Hematology Am Soc Hematol Educ Program 2005:396-402.
32. Sneddon JM. Blood platelets as a model for monoamine-containing neurones. Prog Neurobiol 1973;1:151-198.
33. Henderson LA, Yu PL, Frysinger RC, Galons JP, Bandler R, Harper RM. Neural responses to intravenous serotonin revealed by functional magnetic resonance imaging. J Appl Physiol (1985) 2002;92:331-342.
34. Stroncek DF, Rebulla P. Platelet transfusions. Lancet 2007;370:427-438.
35. Murata S, Hashimoto I, Nakano Y, Myronovych A, Watanabe M, Ohkohchi N. Single administration of thrombopoietin prevents progression of liver fibrosis and promotes liver regeneration after partial hepatectomy in cirrhotic rats. Ann Surg 2008;248:821-828.
36. Furrer K, Rickenbacher A, Tian Y, Jochum W, Bittermann AG, Kach A, et al. Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway. Proc Natl Acad Sci U S A 2011;108:2945-2950.